Nurse Practitioner, Family · Jeffersonville, IN
NPI
1740849637
Since 2019
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
443 Spring St Ste 200
Jeffersonville, IN, 47130
Phone (812) 288-8360
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
786 services
Medicare patients, 2024
121
Average age 72
Drug cost, 2024
$1.2M
10,060 prescriptions
Company payments, 2025
$5,132
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michelle L Vissing was code 99213 (office e&m - established), 384 times for 101 patients. In total Michelle L Vissing billed 786 services in 37 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 384 | 101 | $47.17 | $18K |
| 99214 Office E&M - Established | Office | 55 | 42 | $76.75 | $4,221 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 50 | 50 | $98.31 | $4,916 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 43 | 43 | $14.14 | $608 |
| 80305 Drug Tests | Office | 42 | 22 | $12.35 | $519 |
| 96127 Behavioral Health Services | Office | 35 | 34 | $2.97 | $104 |
| 81002 Clinical Chemistry | Office | 25 | 20 | $3.29 | $82.25 |
| G0008 Administration of influenza virus vaccine | Office | 17 | 16 | $29.40 | $500 |
| 80061 Clinical Chemistry | Office | 15 | 14 | $13.12 | $197 |
| 90653 Vaccine Product | Office | 13 | 13 | $81.18 | $1,055 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 11 | 11 | $9.94 | $109 |
By year: 2022 $40K for 970 services; 2023 $42K for 1,050 services; 2024 $33K for 786 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 42 | 22 | $12.35 | $519 |
| 81002 Clinical Chemistry | 25 | 20 | $3.29 | $82.25 |
| 80061 Clinical Chemistry | 15 | 14 | $13.12 | $197 |
Medicare prescription drug claims, 2024
In 2024, the drug Michelle L Vissing prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 407 prescriptions and refills. In total Michelle L Vissing wrote 10,060 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 407 | 407 | 81 | $8,794 |
| Atorvastatin Calcium Generic | 374 | 855 | 108 | $1,865 |
| Gabapentin Generic | 373 | 519 | 72 | $3,925 |
| Levothyroxine Sodium Generic | 260 | 564 | 65 | $2,151 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 209 | 218 | 61 | $2,626 |
| Omeprazole Generic | 193 | 363 | 49 | $1,017 |
| Potassium Chloride Generic | 175 | 310 | 45 | $1,704 |
| Lisinopril Generic | 173 | 361 | 48 | $438 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 163 | 163 | 33 | $3,600 |
| Amlodipine Besylate Generic | 163 | 345 | 45 | $500 |
| Furosemide Generic | 144 | 217 | 41 | $286 |
| Metoprolol Succinate Generic | 143 | 290 | 40 | $1,066 |
| Pantoprazole Sodium Generic | 142 | 286 | 38 | $1,358 |
| Ozempic Semaglutide | 122 | 135 | 18 | $122K |
| Famotidine Generic | 119 | 255 | 34 | $810 |
Brand drugs: 1,609 claims; generic drugs: 8,399 claims; opioid claims: 763.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michelle L Vissing $5,132 ($5,132 in general payments such as food, travel and fees) from 25 companies. The largest payer was Abbvie Inc. with $2,530.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 27 | $2,530 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $444 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 15 | $243 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 14 | $233 |
| GlaxoSmithKline, LLC. GSK | 15 | $227 |
| Axsome Therapeutics, Inc. AXSM | 13 | $206 |
| Viatris Specialty LLC | 7 | $164 |
| Alkermes, Inc. ALKS | 19 | $161 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 12 | $158 |
| Amgen Inc. AMGN | 6 | $91.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.